In an APP/PS1ΔE9 mouse model expressing human APOE3 or APOE4, TREM2-deficiency increased plaque growth in the early stages of amyloidosis with a decreased microglial response, without affecting an overall level of plaque deposition. The gene discussed is APOE; the disease is amyloidosis.